checkAd

    DGAP-News  458  0 Kommentare STRATEC reports consistent growth in first nine months of 2014 - Seite 2


    million compared with the first nine months of 2013. Alongside high-volume
    established systems and ongoing positive developments in the service parts
    business, key growth drivers included sales from newer systems. Sales
    growth also benefited from increasing volumes of development work, which
    are expected to lead to further positive developments from new market
    launches in the coming years.
    The improvement in the EBIT margin was driven by an increased share of
    sales from service parts, as well as the positive development in the gross
    margin for high-volume systems and growth in the volume of such systems
    sold. Nine-month EBIT increased to EUR 17.7 million, up 37.7% from EUR 12.8
    million in the previous year. This corresponds to an EBIT margin of 16.8%.
    Consolidated net income grew by 43.8% to EUR 14.6 million, and earnings per
    share increased 42.5% to EUR 1.24.

    These earnings figures have been adjusted to exclude a one-off negative
    item resulting from recognition in the first quarter of expenses for the
    remaining years of the term of a management board contract for a retired
    member of the Board of Management and a positive non-operating item due to
    recognition of income for a development project discontinued in 2013. On an
    adjusted basis, EBIT amounted to EUR 17.0 million, the corresponding EBIT
    margin to 16.2%, consolidated net income to EUR 14.2 million and earnings
    per share to EUR 1.20.

    Due to the expiry of a tax concession, the positive impact of lower taxes
    payable on revenues generated in Switzerland will be slightly less marked
    from the coming year onwards.


    Development in personnel

    Including temporary employees, the STRATEC Group had a total of 554
    employees as of September 30, 2014 (September 30, 2013: 544).


    Project development, outlook and financial forecast

    In the current year, STRATEC is focusing on achieving further major
    development milestones, additional market launches, and finalizing
    negotiations for new development and production contracts.

    The recovery in the service parts division has continued. This is due
    primarily to a slight recovery in test volumes at diagnostic laboratories
    in the US in particular and to initial stocking for newly delivered systems
    also.

    Furthermore, the expansion in the company's production and development
    capacities is set to play a major role in the coming quarters. One example
    here is the planned construction of a proprietary development complex at
    STRATEC's location in Romania, where construction work is expected to start
    at the beginning of 2015. The company also plans to extend production areas
    Seite 2 von 4



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News STRATEC reports consistent growth in first nine months of 2014 - Seite 2 DGAP-News: STRATEC Biomedical AG / Key word(s): Quarter Results/Interim Report STRATEC reports consistent growth in first nine months of 2014 22.10.2014 / 07:32 --------------------------------------------------------------------- STRATEC reports …

    Schreibe Deinen Kommentar

    Disclaimer